Experimental treatment with favipiravir for ebola virus disease (the jiki trial): a historically controlled, single-arm proof-of-concept trial in guinea

HIGHLIGHTS

• who: Daouda Sissoko and colleagues from the Institute for Health Research (Inserm, Paris, France) grant from St Luke International University (Tokyo have published the article: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea, in the Journal: (JOURNAL) of 17/Dec/2014
• what: The aims of the trial were to test the feasibility and acceptability of an emergency trial in the context of large Ebola outbreak and to collect on the safety and effectiveness of favipiravir in reducing mortality and viral load . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.